The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
As Americans continue to seek out products to make them sleep, focus, have more energy, and perform better in bed, very little is being discussed about how many of these over-the-counter solutions may have negative health effects in the long term. The irony in this discussion is that there is emerging marketing of products to help people looking for help and relief in these areas being ignored or maligned by some because of one ingredient — THC.
And while over-the-counter products like melatonin for sleep are prevalent across the country, products like those produced by 1906 are still limited to only those states that have legalized cannabis. For 1906 founder and CEO Peter Barsoom, this fact is absurdly out of whack with what he perceives is needed by consumers.
“Melatonin is the most abused and overused supplement in America; it’s not intended to be a daily supplement,” Barsoom told Benzinga. “It’s habit-forming, it makes you groggy and it’s not a sedative.”
1906’s Barsoom believes that his products are predominantly safer, more effective, and the industry’s future, pointing out that “This is cannabis 3.0. Low dose control is where cannabis is going. It’s not about getting high; it’s about feeling a particular way when dealing with issues like sleep, anxiety, and depression.”
Toward New Heights
1906 is leaping over its cannabis pill competition (as exhibited in the chart below), with net revenues growing from $5 million to $12M from 2020 to 2021 and a company estimate to maintain a 240% growth rate into 2022.
Chart provided by 1906 New Highs
“We took a category that didn’t exist. We created the market overnight,” Barsoom added, who says he believes some of the reasons consumers are coming back to his products is that the number of inbound testimonials and demand from partners in new markets proves the company is developing products that people want.
1906 products are now available through licensed dispensary partners in Colorado, Massachusetts, Illinois, and Oklahoma.
For more information on 1906 New Highs, go to www.1906newhighs.com.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
